Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Satellos Bioscience Inc. (MSCLF) had Income from Continuous Operations of $-5.82M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-5.82M |
|
-- |
|
-- |
|
$5.97M |
|
$-5.97M |
|
$0.16M |
|
$-5.80M |
|
$-5.80M |
|
$-5.82M |
|
|
Income from Continuous Operations |
$-5.82M |
$-5.82M |
|
$-5.82M |
|
$-5.97M |
|
$-5.96M |
|
167.34M |
|
167.34M |
|
$-0.03 |
|
$-0.03 |
|
| Balance Sheet Financials | |
$37.50M |
|
$0.01M |
|
$0.01M |
|
$37.50M |
|
$3.50M |
|
-- |
|
-- |
|
$3.50M |
|
$34.00M |
|
$34.00M |
|
$34.00M |
|
185.09M |
|
| Cash Flow Statement Financials | |
$-16.34M |
|
$-6.86M |
|
$2.09M |
|
$40.07M |
|
$19.30M |
|
$-20.77M |
|
$2.25M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.70 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-16.34M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-17.12% |
|
-17.12% |
|
-15.52% |
|
-17.12% |
|
$0.18 |
|
$-0.10 |
|
$-0.10 |
|